Ablynx.com / Board of Directors

Three-dimensional structure of a Nanobody^®(modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home

ABOUT ABLYNX

Board of directors > Mats Petterson

Board of Directors

Mats Pettersson

Mats Petterson has obtained a bachelor of science in Economics and Business Administration. He is the founder of Biovitrum AB, a spin out company from Pharmacia and one of the largest Biotech companies in Europe, and he was its first CEO from 2001 until 2007. After a career as a CPA (1968-1976) he joined the Pharmacia group in 1976 where he mainly worked in CFO and Business Development positions. Before founding Biovitrum, he was Senior Vice President and a member of the management committee of Pharmacia Corporation. He has been responsible for most of the transforming mergers in Pharmacia and has spent more than 16 years abroad in his career. He is currently a board member of Lundbeck A\S and founder and vice chairman of Sweden Bio. In the past, he has held Board memberships with , Biacore International AB (Sweden) and Active Biotech AB (Sweden).